Cieplinska Agnieszka 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Jul 1, 2020
Insider Transaction Report
Form 4
Cieplinska Agnieszka
Chief Accounting Officer (PAO)
Transactions
- Award
Restricted Stock Units
2020-06-29+3,150→ 9,450 total→ Common Stock (3,150 underlying) - Sale
Common Stock
2020-06-30$35.11/sh−947$33,249→ 7,574 total - Award
Common Stock
2020-06-29+3,150→ 8,521 total
Footnotes (4)
- [F1]Shares received pursuant to settlement of Performance Stock Units that were granted on April 12,2019.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- [F4]Subject to the officer's continued employment with the company, 3,150 Restricted Stock Units will vest on June 29, 2021.